Cargando…
Molecular and cellular mechanisms of pulmonary fibrosis
Pulmonary fibrosis is a chronic lung disease characterized by excessive accumulation of extracellular matrix (ECM) and remodeling of the lung architecture. Idiopathic pulmonary fibrosis is considered the most common and severe form of the disease, with a median survival of approximately three years...
Autores principales: | Todd, Nevins W, Luzina, Irina G, Atamas, Sergei P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443459/ https://www.ncbi.nlm.nih.gov/pubmed/22824096 http://dx.doi.org/10.1186/1755-1536-5-11 |
Ejemplares similares
-
Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis
por: Todd, Nevins W, et al.
Publicado: (2013) -
Survival in pulmonary fibrosis combined with emphysema: likely defined by characteristics of specific patient subpopulations
por: Todd, Nevins W, et al.
Publicado: (2011) -
Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History
por: Kalchiem-Dekel, Or, et al.
Publicado: (2018) -
Combined Pulmonary Fibrosis and Emphysema: Pulmonary Function Testing and a Pathophysiology Perspective
por: Amariei, Diana E., et al.
Publicado: (2019) -
CCR6 is not necessary for functional effects of human CCL18 in a mouse model
por: Luzina, Irina G, et al.
Publicado: (2012)